This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Korah, R. Articles by Wieder, R. Search for Related Content PubMed PubMed Citation Articles by Korah, R. Articles by Wieder, R.

Integrin 5ß1 Promotes Survival of Growth-Arrested Breast Cancer Cells

An in Vitro Paradigm for Breast Cancer Dormancy in Bone Marrow

Division of Oncology/Hematology, Department of Medicine, University of Medicine and Dentistry of New Jersey-New Jersey Medical School, Newark, New Jersey

The mechanisms of long-term survival of occult breast cancer cells in the bone marrow microenvironment are not known. Using selected bone marrow stromal components with demonstrated roles in promoting growth arrest and survival of breast cancer cells, we reconstituted an in vitro model for dormancy of breast cancer cells in bone marrow. According to this model, basic fibroblast growth factor, a mammary differentiation factor abundant in the bone marrow stroma, induces growth arrest of relatively well-differentiated breast cancer cells, induces a spread appearance, and restricts their survival to fibronectin by up-regulating integrin 5ß1. Most of the basic fibroblast growth factor-arrested cells fail to establish optimal ligation to fibronectin and undergo cell death. Cells that do attach to fibronectin, another major constituent of the bone marrow microenvironment, stay alive and growth-arrested for many weeks. Although capable of adhering to other stromal proteins collagen and laminin, dormant cells do not gain a survival advantage from these interactions. Using function-blocking peptides, we show a specific contribution of 5ß1-fibronectin interaction in maintaining survival of growth-arrested cells, potentially by negatively modulating apoptotic response via signaling pathways. Blocking of phosphatidylinositol 3'-kinase and Akt inhibits survival of dormant clones, demonstrating this as one of those pathways. Experiments with human bone marrow stroma cocultures confirm the role of fibronectin ligation in maintaining survival of dormant clones.

This article has been cited by other articles:

				D. Barkan, H. Kleinman, J. L. Simmons, H. Asmussen, A. K. Kamaraju, M. J. Hoenorhoff, Z.-y. Liu, S. V. Costes, E. H. Cho, S. Lockett, et al. Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton Cancer Res., August 1, 2008; 68(15): 6241 - 6250. [Abstract] [Full Text] [PDF]

				A Vincent-Salomon, F C Bidard, and J Y Pierga Bone marrow micrometastasis in breast cancer: review of detection methods, prognostic impact and biological issues J. Clin. Pathol., May 1, 2008; 61(5): 570 - 576. [Abstract] [Full Text] [PDF]

				J. Y. Fok, S. Ekmekcioglu, and K. Mehta Implications of tissue transglutaminase expression in malignant melanoma. Mol. Cancer Ther., June 1, 2006; 5(6): 1493 - 1503. [Abstract] [Full Text] [PDF]

				E. Fitzpatrick, S. McBride, J. Yavelow, S. Najmi, P. Zanzucchi, and R. Wieder Microfluidic Techniques for Single-Cell Protein Expression Analysis Clin. Chem., June 1, 2006; 52(6): 1080 - 1088. [Abstract] [Full Text] [PDF]

				C. Spangenberg, E. U. Lausch, T. M. Trost, D. Prawitt, A. May, R. Keppler, S. A. Fees, D. Reutzel, C. Bell, S. Schmitt, et al. ERBB2-Mediated Transcriptional Up-regulation of the {alpha}5{beta}1 Integrin Fibronectin Receptor Promotes Tumor Cell Survival Under Adverse Conditions. Cancer Res., April 1, 2006; 66(7): 3715 - 3725. [Abstract] [Full Text] [PDF]

				S. Han, F. R. Khuri, and J. Roman Fibronectin Stimulates Non-Small Cell Lung Carcinoma Cell Growth through Activation of Akt/Mammalian Target of Rapamycin/S6 Kinase and Inactivation of LKB1/AMP-Activated Protein Kinase Signal Pathways Cancer Res., January 1, 2006; 66(1): 315 - 323. [Abstract] [Full Text] [PDF]

				J. B. Fleming, G.-L. Shen, S. E. Holloway, M. Davis, and R. A. Brekken Molecular Consequences of Silencing Mutant K-ras in Pancreatic Cancer Cells: Justification for K-ras-Directed Therapy Mol. Cancer Res., July 1, 2005; 3(7): 413 - 423. [Abstract] [Full Text] [PDF]

				C. M. Shachaf and D. W. Felsher Tumor Dormancy and MYC Inactivation: Pushing Cancer to the Brink of Normalcy Cancer Res., June 1, 2005; 65(11): 4471 - 4474. [Abstract] [Full Text] [PDF]

				S. Najmi, R. Korah, R. Chandra, M. Abdellatif, and R. Wieder Flavopiridol Blocks Integrin-Mediated Survival in Dormant Breast Cancer Cells Clin. Cancer Res., March 1, 2005; 11(5): 2038 - 2046. [Abstract] [Full Text] [PDF]